A Russian company wants to manufacture a vaccine against the coronavirus in Bavaria.
Germany should not be supplied with it.
The number of Corona * cases is increasing worldwide.
A Russian company wants to manufacture a vaccine in Bavaria.
Germany should not be supplied with the vaccine.
Here you will find the basic facts about the coronavirus * and the corona news from Bavaria.
We also offer you the current case numbers in Bavaria on a map.
Illertissen - Russia sees itself at the forefront of international research with its corona vaccine *.
However, Russian companies
have also
entered into
collaborations
with other pharmaceutical groups, and a plant in Bavaria is now benefiting from this.
The news channel
ntv
reports
.
Coronavirus vaccine: Russian company invests in Illertissen location in Bavaria
The Russian pharmaceutical company
R-Pharm is
investing millions in the expansion of the
Illertissen
site in Bavaria
.
More than 20 million euros are to be invested in the plant there, as site manager Ivan Semenov
told
Südwest Presse
.
Production of a so-called
Oxford vaccine
against the
coronavirus is
scheduled to start there in the first quarter of 2021
.
The Russian
parent
company is investing in a sterile production facility in Illertissen, as
ntv
continues to report.
The capacity is designed for 500 million
vaccine doses
a year.
35 countries are to be supplied with the vaccine, including the CIS countries (Commonwealth of Independent States).
These include, for example, Russia, Kazakhstan and Armenia.
Germany
or other EU countries should not be supplied.
The Oxford vaccine (AZD1222) is currently in
testing
phase
III
,
i.e.
the crucial phase.
Company from #Russia manufactures #Corona vaccine in Bavaria https://t.co/KMBIjhWbWG
- Axel Huckstorf (@axelhuckstorf) September 5, 2020
AstraZeneca's corona vaccine candidate: three billion vaccine doses per year?
The vaccine candidate from pharmaceutical company AstraZeneca has
reached late stage clinical development
in the
United States
.
For the third phase of the
study
, only up to 30,000 participants are being sought to test the vaccine, as the company recently announced.
In July, the company announced that an early to mid-stage study had shown that the vaccine was "well tolerated and produced robust immune responses *" against the
virus
. Further
tests are
to be carried out in Brazil, South Africa and Russia, according to the
Independent
The pharmaceutical company has already signed
production
agreements with various countries, including Russia.
An annual production of three billion
vaccine doses is
targeted.
A few weeks ago, the EU had also signed a supply agreement with
AstraZeneca
for 400 cans, as
ntv
further reported.
The plant in Illertissen may also manufacture the “Sputnik V” vaccine at a later date.
It is already approved in Russia - despite concerns.
A vacationer from Germany disregarded a corona rule on a trip to Norway - it was expensive for him.
In the video: Scientists warn of the Russian corona vaccine
You can always read all the news from Bavaria with us.
(came) * Merkur.de is part of the nationwide Ippen-Digital editors network.